Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines

The current study describes, a novel combinatorial library of substituted fused pyrimido[3,2–e]pyrrolo[1,2-a]piperazine and pyrido[3,2-b]pyrrolo[1,2-d][1,4]diazepin heterocycles procured via utilization of suzuki coupling and acid amine coupling protocols. The synthesized compounds were screened for...

Full description

Bibliographic Details
Main Authors: Jignesh B. Timaniya, Paranjay H. Parikh, Mrugesh J. Patel, Gayatri Dave, Kaushal P. Patel
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Results in Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221171562200426X
_version_ 1797799084241715200
author Jignesh B. Timaniya
Paranjay H. Parikh
Mrugesh J. Patel
Gayatri Dave
Kaushal P. Patel
author_facet Jignesh B. Timaniya
Paranjay H. Parikh
Mrugesh J. Patel
Gayatri Dave
Kaushal P. Patel
author_sort Jignesh B. Timaniya
collection DOAJ
description The current study describes, a novel combinatorial library of substituted fused pyrimido[3,2–e]pyrrolo[1,2-a]piperazine and pyrido[3,2-b]pyrrolo[1,2-d][1,4]diazepin heterocycles procured via utilization of suzuki coupling and acid amine coupling protocols. The synthesized compounds were screened for their in vitro cytotoxic activity over nine different cancer cell lines such as U-251, Panc-1, MCF-7, HepG2, DU-145, A549, 786-O, OVCAR3 and HCT-116 as well as on non-cancerous cell lines like normal human lung cell line WI38 and Mouse embryonic normal cell line NIH3T3 to evaluate safety profile of synthesized compounds. The bioassay results indicates that compound Cpd-J2 to be most potent among all the synthesized compounds towards ovary cancer cell lines (OVCAR-3) with promising activity value (EC50: 6.3 μM) relative to standard doxorubicin (EC50: 0.2 μM).
first_indexed 2024-03-13T04:13:36Z
format Article
id doaj.art-7c94e99778104d2e95d0dc87820c7293
institution Directory Open Access Journal
issn 2211-7156
language English
last_indexed 2024-03-13T04:13:36Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Results in Chemistry
spelling doaj.art-7c94e99778104d2e95d0dc87820c72932023-06-21T06:51:41ZengElsevierResults in Chemistry2211-71562023-01-015100707Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell linesJignesh B. Timaniya0Paranjay H. Parikh1Mrugesh J. Patel2Gayatri Dave3Kaushal P. Patel4Department of Advanced Organic Chemistry, P. D. Patel Institute of Applied Sciences, Charotar University of Science and Technology, Gujarat 388421, IndiaDepartment of Advanced Organic Chemistry, P. D. Patel Institute of Applied Sciences, Charotar University of Science and Technology, Gujarat 388421, IndiaDepartment of Advanced Organic Chemistry, P. D. Patel Institute of Applied Sciences, Charotar University of Science and Technology, Gujarat 388421, IndiaDepartment of Biological Sciences, P. D. Patel Institute of Applied Sciences, Charotar University of Science and Technology, Gujarat 388421, IndiaDepartment of Advanced Organic Chemistry, P. D. Patel Institute of Applied Sciences, Charotar University of Science and Technology, Gujarat 388421, India; Corresponding author.The current study describes, a novel combinatorial library of substituted fused pyrimido[3,2–e]pyrrolo[1,2-a]piperazine and pyrido[3,2-b]pyrrolo[1,2-d][1,4]diazepin heterocycles procured via utilization of suzuki coupling and acid amine coupling protocols. The synthesized compounds were screened for their in vitro cytotoxic activity over nine different cancer cell lines such as U-251, Panc-1, MCF-7, HepG2, DU-145, A549, 786-O, OVCAR3 and HCT-116 as well as on non-cancerous cell lines like normal human lung cell line WI38 and Mouse embryonic normal cell line NIH3T3 to evaluate safety profile of synthesized compounds. The bioassay results indicates that compound Cpd-J2 to be most potent among all the synthesized compounds towards ovary cancer cell lines (OVCAR-3) with promising activity value (EC50: 6.3 μM) relative to standard doxorubicin (EC50: 0.2 μM).http://www.sciencedirect.com/science/article/pii/S221171562200426XPyridoPyrimido PiperazineAzepineAnticancer
spellingShingle Jignesh B. Timaniya
Paranjay H. Parikh
Mrugesh J. Patel
Gayatri Dave
Kaushal P. Patel
Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines
Results in Chemistry
Pyrido
Pyrimido Piperazine
Azepine
Anticancer
title Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines
title_full Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines
title_fullStr Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines
title_full_unstemmed Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines
title_short Design, synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives: In vitro cytotoxicity study over various cancer cell lines
title_sort design synthesis and evaluation of novel substituted fused pyrido diazepine and pyrimido piperazine derivatives in vitro cytotoxicity study over various cancer cell lines
topic Pyrido
Pyrimido Piperazine
Azepine
Anticancer
url http://www.sciencedirect.com/science/article/pii/S221171562200426X
work_keys_str_mv AT jigneshbtimaniya designsynthesisandevaluationofnovelsubstitutedfusedpyridodiazepineandpyrimidopiperazinederivativesinvitrocytotoxicitystudyovervariouscancercelllines
AT paranjayhparikh designsynthesisandevaluationofnovelsubstitutedfusedpyridodiazepineandpyrimidopiperazinederivativesinvitrocytotoxicitystudyovervariouscancercelllines
AT mrugeshjpatel designsynthesisandevaluationofnovelsubstitutedfusedpyridodiazepineandpyrimidopiperazinederivativesinvitrocytotoxicitystudyovervariouscancercelllines
AT gayatridave designsynthesisandevaluationofnovelsubstitutedfusedpyridodiazepineandpyrimidopiperazinederivativesinvitrocytotoxicitystudyovervariouscancercelllines
AT kaushalppatel designsynthesisandevaluationofnovelsubstitutedfusedpyridodiazepineandpyrimidopiperazinederivativesinvitrocytotoxicitystudyovervariouscancercelllines